Feedback / Questions
Kombiglyze XR (saxagliptin + metformin XR) - AstraZeneca
AstraZeneca: Annual Report 2013
(AstraZeneca)
-
Mar 21, 2014 -
Anticipated composition of matter patent expiry in US in 2023; Anticipated composition of matter patent expiry in EU in 2026
Anticipated patent expiry
•
Diabetes
http://www.astrazeneca-annualreports.com/2013/_assets/pdfs/AstraZeneca_Annual_Report_2013.pdf
Mar 21, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.